Continuing Education

Trends in Patient Access to and Utilization of Prescribed PCSK9 Inhibitors in a Large US Claims Database From 2015 to 2021

February 17, 2024 Editor

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.

← Why Does a Cardiologist Believe in a Therapy? The Role of Intuitiveness and Understanding the Mechanism
Racial Differences in Donor-Derived Cell-Free DNA and Mitochondrial DNA After Heart Transplantation, on Behalf of the GRAfT Investigators →